TCMBANKIN012488 |
5,3'-dibutanoyloxy-3,6, 7,4'-tetramethoxyflavone |
|
C27H30O10 |
|
CCCC(=O)OC1=C(C=CC(=C1)C2=C(C(=O)C3=C(C(=C(C=C3O2)OC)OC)OC(=O)CCC)OC)OC |
TCMBANKIN021002 |
5-(3d- methyloctyl)furan-8-methoxy-coumarin |
|
|
|
|
TCMBANKIN022840 |
hydroxyisopiloselloidone |
|
C18H24O4 |
304.38 |
CC(C)CC(=O)C1=CC(=CC(=C1O)C=CC(C)(C)O)C(=O)C |
TCMBANKIN023027 |
3-benzoylsiaresinolic acid |
|
|
576.89 |
|
TCMBANKIN026702 |
5,3'-dipropanoyloxy-3,6,7,4'-tetramethoxy-fla-vone |
|
C25H26O10 |
|
CCC(=O)OC1=C(C=CC(=C1)C2=C(C(=O)C3=C(C(=C(C=C3O2)OC)OC)OC(=O)CC)OC)OC |
TCMBANKIN027128 |
aucubigenin |
64274-28-8; (1R,4aR,5S,7aS)-7-(hydroxymethyl)-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-1,5-diol; Cyclopenta(c)pyran-1,5-diol, 1,4a,5,7a-tetrahydro-7-(hydroxymethyl)-, (1R-(1alpha,4aalpha,5alpha,7aalpha))-; (1R,4aR,5S,7aS)-7-methylol-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-1,5-diol |
C9H12O4 |
184.19 |
C1=COC(C2C1C(C=C2CO)O)O |
TCMBANKIN028506 |
5,3'-dihexanoyloxy-3,6, 7,4'-tetramethoxyflavone |
|
C31H38O10 |
|
CCCCCC(=O)OC1=C(C=CC(=C1)C2=C(C(=O)C3=C(C(=C(C=C3O2)OC)OC)OC(=O)CCCCC)OC)OC |
TCMBANKIN031617 |
5-Hydroxyl-3,4′,6,7-tetramethoxyfl avone |
|
|
|
|
TCMBANKIN033670 |
acerosin |
|
C18H16O8 |
360.3 g/mol |
COC1=C(C=C(C=C1)C2=CC(=O)C3=C(C(=C(C(=C3O2)OC)O)OC)O)O |
TCMBANKIN039992 |
3,5,6,7,8-pentahydroxy-2-(4-methoxyphenyl)-4h-1-benzopyran-4-one |
|
C16H12O8 |
332.26 g/mol |
COC1=CC=C(C=C1)C2=C(C(=O)C3=C(C(=C(C(=C3O2)O)O)O)O)O |
TCMBANKIN043253 |
5,3'-dibenzoyloxy-3,6,7,4'-tetramethoxyflavone |
|
C33H26O10 |
|
COC1=C(C=C(C=C1)C2=C(C(=O)C3=C(C(=C(C=C3O2)OC)OC)OC(=O)C4=CC=CC=C4)OC)OC(=O)C5=CC=CC=C5 |
TCMBANKIN046578 |
Negundoside |
|
|
496.5 g/mol |
|
TCMBANKIN047425 |
Nishindaside |
|
|
498.48 |
|
TCMBANKIN061477 |
vitexicarpin |
4H-1-Benzopyran-4-one, 5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-3,6,7-trimethoxy-; Casticine; SCHEMBL382354; 5-Hydroxy-2-(3-hydroxy-4-methoxyphenyl)-3,6,7-trimethoxy-4H-1-benzopyran-4-one; MolPort-005-938-589; 3',5-Dihydroxy-3,4',6,7-tetramethoxyflavone; Quercetagetin 3,6,7,4'-tetramethyl ether; 3',5-dihydroxy-3,4',6,7-tetramethoxyflavone; 5-Hydroxy-2-(3-hydroxy-4-methoxyphenyl)-3,6,7-trimethoxy-4H-benzopyran-4-one, 9CI; ZINC6018556; Q-100515; PJQLSMYMOKWUJG-UHFFFAOYSA-N; 4H-1-Benzopyran-4-one,5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-3,6,7-trimethoxy-; 3,6,7,4'-Tetra-O-methyl-5,3'-dihydroxyflavone; NP-001928; I07-0245; Casticin; V1552; Casticin, United States Pharmacopeia (USP) Reference Standard; casticin; AKOS015896773; CHEMBL452767; 5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-3,6,7-trimethoxychromen-4-one; AC1NSSVS; 3,6,7,4'-tetramethylquercetagetin; FT-0688327; 5-hydroxy-2-(3-hydroxy-4-methoxy-phenyl)-3,6,7-trimethoxy-chromen-4-one; Vitexicarpin; 3-,5-Dihydroxy-3,4-,6,7-tetramethoxyflavone; DTXSID80197326; CHEBI:69355; Casticin(Vitexicarpin); AK554014; AN-10374; Agnus castus fruit standardised dry extract, European Pharmacopoeia (EP) Reference Standard; 479-91-4; 753GT729OU; 479V914; Agnus castus fruit dry extract, European Pharmacopoeia (EP) Reference Standard; vitexicarpin ; AC-6085; Casticin, analytical standard; N1318; Agnus castus fruit standardised dry extract; LMPK12113010; Casticin, primary pharmaceutical reference standard; 5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-3,6,7-trimethoxy-4H-chromen-4-one; UNII-753GT729OU;casticin;vitxicarpin |
C19H18O8 |
374.34 g/mol |
COC1=C(C=C(C=C1)C2=C(C(=O)C3=C(C(=C(C=C3O2)OC)OC)O)OC)O |
TCMBANKIN061722 |
chrysosplenol g |
5,3'-dihydroxy-3,7,4',5'-tetramethoxyflavone |
C19H18O8 |
374.3 g/mol |
COC1=CC(=C2C(=C1)OC(=C(C2=O)OC)C3=CC(=C(C=C3OC)OC)O)O |